When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALXN - European advisory groups thumbs up on Alexion's Ultomiris for PNH
Alexion Pharmaceuticals Inc.
The European Medicines Agency's advisory group CHMP has adopted a positive opinion recommending approval for Alexion Pharmaceuticals' (ALXN-1.5%) Ultomiris (ravulizumab) for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH) with hemolysis with clinical symptoms and who are clinically stable after receiving Soliris (eculizumab) for at least the past six months.
More news on: Alexion Pharmaceuticals, Inc., Healthcare stocks news,